Guselkumab

{{Infobox drug | type = mab | image = Tremfya, 100 mg, Guselkumab, autoinjector-6177.jpg | alt = An autoinjector with 100 mg Tremfya, Guselkumab, | caption = A Tremfya bulb-style injection. | mab_type = mab | source = u | target = IL23 |…

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Guselkumab ( ; sold under the brand name Tremfya) is a human monoclonal antibody against interleukin-23 used for the treatment of plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease.

Pharmacokinetics

C max 8.09 μg/mL t max 5.5 days volume of distribution 13.5 L apparent clearance 0.516 L/day

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368726696 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

17 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.